Radiochemical catalog

A  catalog of novel and exclusive radiolabeled tool compounds for laboratory research

Our collection covers radiolabeled life science reagents such as e.g., GPCR and transporter ligands, signaling inhibitors, and ion channel modulators. We can also provide labeling reagents for your own labeling projects.

We regularly ship to North America, Europe and Asia. The products are delivered in clear thick wall glass vials with conical bottoms for high recovery. Volatile products are shipped in prescored flame sealed. Our products are accompanied by an AntiTipStandⒹ, which allows for safe and convenient dispensing and storage in a leak tight secondary container.

Is there something you think we should include in the catalog? Then please contact us and let us know.

Category

Search

Reset filter

(+)-MK-801, [³H]

N-Methyl-D-aspartate (NMDA) receptor antagonist

(L)-Deprenyl, [³H]

Monoamine oxidase B (MAO-B) ligand

(R)-(+)-7-OH-DPAT, [³H]

Dopamine D₃ agonist

(S,S)-MeNER, [³H]

Norepinephrine reuptake/transporter inhibitor

(S)-Citalopram, [³H]

Serotonin reuptake/transporter inhibitor

N-Desmethyl clozapine, [³H]

Clozapine metabolite

N-Methylspiperone, [³H]

Dopamine D2 and serotonin 5-HT2A receptor antagonist

N-Succinimidyl propionate, [³H]

Labeling reagent

N-Methylscopolamine, [³H]

Muscarinic mAChR antagonist

A-836339, [³H]

Cannabinoid CB₂ receptor agonist

A-85380, [³H]

High affinity and selective α4β2 agonist

A-971432, [³H]

Sphingosine-1-phosphate (S1P5) receptor agonist

AF-DX 384, [³H]

Muscarinic M2 and M4 receptor antagonist

Allopregnanolone, [³H]

Endogenous inhibitory pregnant neurosteroid, Positive allosteric modulator of the GABAA receptor

Almorexant, [³H]

Dual OX₁ and OX₂ receptor antagonist

ASEM, [³H]

α7 nicotinic acetylcholine receptor ligand.

AZ10419369, [³H]

Serotonin 5-HT1B receptor antagonist

AZD2184, [³H]

ß-Amyloid ligand

BCPP-EF, [³H]

Mitochondrial complex 1 (MC-1) ligand

BPTU, [³H]

Purinergic P2Y1 allosteric antagonist

BU99008, [³H]

Imidazoline I2 receptor ligand

Candesartan, [³H]

Angiotensin II receptor type 1 (AT1) antagonist

Cannabidiol, [³H]

Phytocannabinoid

CGS 9895, [³H]

GABAA modulator

CHDI-180, [³H]

Mutant huntingtin (mHTT) protein aggregate ligand

Cimbi-36, [³H]

Serotonin 5-HT2A receptor agonist

Citalopram (racemic), [³H]

Serotonin reuptake/transporter inhibitor

Clozapine-N-oxide, [³H]

Clozapine metabolite

Clozapine, [³H]

Atypical antipsychotic drug

Cortisone, [³H]

Steroid hormone

CPPC, [³H]

CSF-1R (c-Fms kinase) inhibitor

CS1P1, [³H]

Sphingosine-1-phosphate receptor (S1PR) ligand

DAMGO, [³H]

μ opioid receptor agonist

DASB, [³H]

Serotonin reuptake/transporter inhibitor

DPA-714, [³H]

Translocator protein (TSPO) ligand

DPCPx, [³H]

Adenosine A1 receptor antagonist

EMPA, [³H]

OX2 receptor antagonist

Estrone 3-sulfate, Ammonium Salt-, [6,9-³H]

Endogenous steroid

Fallypride, [³H]

Dopamine D2/D3 receptor antagonist

FE-PE2I, [³H]

Dopamine reuptake/transporter inhibitor

Flumazenil, [³H]

GABAA receptor antagonist

Fluoroethyl tosylate, [³H]

Labeling reagent

Galanin (human), [³H]

Endogenous galanin receptor agonist

GBR-12935, [³H]

Dopamine reuptake/transporter inhibitor

GNE-9605, [³H]

Leucine-rich repeat kinase 2 (LRRK2) inhibitor

GR 125743, [³H]

Serotonin 5-HT1B/1D receptor antagonist

GW2580, [³H]

CSF-1R (c-Fms kinase) inhibitor

Harmine, [³H]

Reversible monoamine oxidase A inhibitor

Imipramine, [³H]

Serotonin and norepinephrine reuptake/transporter inhibitor

Isoallopregnanolone, [³H]

Endogenous neurosteroid, Negative allosteric modulator of the GABAA receptor

Ketanserin, [³H]

Serotonin 5-HT2A receptor antagonist

LRRK2-IN-1, [³H]

LRRK2 inhibitor

LY 341495, [³H]

Metabotropic Glutamate Receptor 2 (mGluR2) antagonist

M-MTEP, [³H]

Metabotropic Glutamate Receptor 5 (mGluR5) antagonist

MC1, [³H]

Cyclooxygenase COX-2 inhibitor

MDL-100.907, [³H]

Serotonin 5-HT2A receptor antagonist

Methoxy-PEPy, [³H]

Metabotropic Glutamate Receptor 5 (mGluR5) antagonist

MK-6884, [³H]

Muscarinic M4 receptor positive allosteric modulator (PAM)

MNI-659, [³H]

Phosphodiesterase 10A (PDE10A) inhibitor

MPC-6827, [³H]

Microtubule ligand

MPP+, [³H]

Neurotoxin

Naltrindole, [³H]

Delta δ opioid antagonist

Nisoxetine, [³H]

Norepinephrine reuptake (NET) inhibitor

Nociceptin, [³H]

Nociceptin receptor ligand

NS10743, [³H]

α7 nicotinic acetylcholine receptor ligand

NS14492, [³H]

α7 nicotinic acetylcholine receptor ligand

Ozanimod, [³H]

Sphingosine-1-phosphate (S1P1 and S1P5) receptor agonist

PBR28, [³H]

Translocator protein (TSPO) ligand

PF-06447475, [³H]

LRRK2 inhibitor

Pirenzepine, [³H]

Muscarinic M1 receptor antagonist

Prazosin, [³H]

α1 and α2B adrenoceptor antagonist

Pregnanolone, [³H]

Endogenous neurosteroid, Positive allosteric modulator of the GABAA receptor

PS13, [³H]

Cyclooxygenase COX-1 inhibitor

Pyrilamine, [³H]

Histamine H1 receptor antagonist

Raclopride, [³H]

Dopamine D2 receptor antagonist

Ro 41-1049, [³H]

Reversible monoamine oxidase A inhibitor

RS-127445, [³H]

Serotonin 5-HT2B receptor antagonist

RX 821002, [³H]

α2-adrenoceptor antagonist

SA4503, [³H]

Sigma-1 (σ1) receptor agonist

SB-258585, [³H]

Serotonin 5-HT6 receptor antagonist

SB-674042, [³H]

OX1 receptor antagonist

SCH 23390, [³H]

Dopamine D1 and D5 receptor antagonist

SIL26, [³H]

α-Synuclein ligand

SMW139, [³H]

Purinergic P2X7 receptor allosteric antagonist

SR141716A, [³H]

Cannabinoid receptor CB1 inverse agonist

Sulpiride, [³H]

Dopamine D2 receptor antagonist

SynVesT-1, [³H]

Synaptic vesicle protein 2A (SV2A) ligand

T807, [³H]

Microtubule-associated protein tau ligand

THDOC, [³H]

Endogenous neurosteroid

THK-5117, [³H]

Microtubule-associated protein tau ligand

THK-5351, [³H]

Microtubule-associated protein tau ligand

Tiagabine, [³H]

GAT-1 selective GABA uptake inhibitor

Tropisetron, [³H]

Serotonin 5-HT3 receptor antagonist

U-69593, [³H]

Kappa κ1-opioid receptor agonist

UCB-J, [³H]

Synaptic vesicle protein 2A (SV2A) ligand

VAT, [³H]

Vesicular acetylcholine transporter inhibitor

WAY100635, [³H]

Serotonin 5-HT1A receptor antagonist

WIN 35,428, [³H]

Dopamine reuptake/transporter inhibitor

ZM 241385, [³H]

Adenosine A2A antagonist